Junto Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$149M |
| 2 |
Procter & Gamble
PG
|
+$103M |
| 3 |
Mastercard
MA
|
+$93.1M |
| 4 |
RTX Corp
RTX
|
+$84.8M |
| 5 |
Southern Company
SO
|
+$83.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$177M |
| 2 |
Union Pacific
UNP
|
+$123M |
| 3 |
CVS Health
CVS
|
+$111M |
| 4 |
JPMorgan Chase
JPM
|
+$107M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$94.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.52% |
| 2 | Consumer Discretionary | 21.96% |
| 3 | Healthcare | 11.11% |
| 4 | Technology | 10.08% |
| 5 | Consumer Staples | 9.58% |
Similar funds
Junto Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Junto Capital Management held 105 positions worth $4.52B, up 1% from $4.47B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Junto Capital Management withdrew a net $434M in Q1 2024, closing 33 positions and reducing 29 holdings. Its most notable exit was Union Pacific, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Junto Capital Management opened a new position in Elevance Health worth $155M.
- Junto Capital Management's largest Q1 2024 buy was Elevance Health: 299,388 shares worth $155M.
- Junto Capital Management added most to Royal Caribbean in Q1 2024, an estimated $58.3M increase.
- Junto Capital Management's biggest Q1 2024 reduction was KKR & Co, cutting an estimated $177M.
- Junto Capital Management fully exited Union Pacific in Q1 2024, selling an estimated $123M.
- Junto Capital Management's ten largest holdings make up 27% of its $4.52B portfolio in Q1 2024.
- Junto Capital Management opened 29 new positions and closed 33 in Q1 2024.
- Junto Capital Management's portfolio value rose 1% quarter-over-quarter to $4.52B.
Based on Junto Capital Management's 13F filing for Q1 2024, filed 15 May 2024.